糖尿病视网膜病变的流行病学、危险因素、筛查和治疗的最新进展。
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy.
机构信息
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
出版信息
J Diabetes Investig. 2021 Aug;12(8):1322-1325. doi: 10.1111/jdi.13480. Epub 2021 Jan 14.
Abstract
Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.
摘要
尽管在治疗糖尿病性黄斑水肿和糖尿病性视网膜病变方面取得了进展，但由于医疗资源的限制，眼底检查率较低，导致糖尿病性视网膜病变的诊断和治疗延迟。因此，实施自动化糖尿病视网膜病变筛查计划和识别更特异和敏感的生物标志物对于促进更早地发现糖尿病性黄斑水肿和糖尿病性视网膜病变，降低视力不佳和失明的发生率非常重要。
相似文献
1
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy.糖尿病视网膜病变的流行病学、危险因素、筛查和治疗的最新进展。
J Diabetes Investig. 2021 Aug;12(8):1322-1325. doi: 10.1111/jdi.13480. Epub 2021 Jan 14.
2
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.糖尿病性视网膜病变。失明的筛查与预防。博士论文。
Acta Ophthalmol Scand Suppl. 1997(223):1-76.
3
Screening for and managing diabetic retinopathy: current approaches.糖尿病视网膜病变的筛查与管理：当前方法
Am J Health Syst Pharm. 2007 Sep 1;64(17 Suppl 12):S8-14. doi: 10.2146/ajhp070331.
4
Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus.近期诊断为糖尿病患者的糖尿病视网膜病变患病率
Clin Exp Optom. 2011 Jul;94(4):371-5. doi: 10.1111/j.1444-0938.2010.00574.x. Epub 2011 Feb 16.
5
Prevalence and associated factors of diabetic retinopathy among people with diabetes screened using fundus photography at a community diabetic retinopathy screening program in Nepal.在尼泊尔的一个社区糖尿病视网膜病变筛查计划中，使用眼底摄影筛查糖尿病患者的糖尿病视网膜病变患病率及其相关因素。
BMC Ophthalmol. 2023 Oct 23;23(1):429. doi: 10.1186/s12886-023-03173-z.
6
Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study.中国已知糖尿病患者中糖尿病视网膜病变的患病率：北京眼病研究
Eur J Ophthalmol. 2009 Jan-Feb;19(1):91-9. doi: 10.1177/112067210901900114.
7
Diabetic retinopathy: Early diagnosis and effective treatment.糖尿病性视网膜病变：早期诊断与有效治疗。
Dtsch Arztebl Int. 2010 Feb;107(5):75-83; quiz 84. doi: 10.3238/arztebl.2010.0075. Epub 2010 Feb 5.
8
Current epidemiology of diabetic retinopathy and diabetic macular edema.糖尿病视网膜病变和糖尿病黄斑水肿的当前流行病学。
Curr Diab Rep. 2012 Aug;12(4):346-54. doi: 10.1007/s11892-012-0283-6.
9
Pattern of diabetic retinopathy in Kano, Nigeria.尼日利亚卡诺市糖尿病视网膜病变的模式
Ann Afr Med. 2012 Apr-Jun;11(2):75-9. doi: 10.4103/1596-3519.93528.
10
Evaluating the effectiveness of opportunistic eye screening model for people with diabetes attending diabetes clinic at Mnazi Mmoja Hospital, Zanzibar.评估在桑给巴尔 Mnazi Mmoja 医院糖尿病诊所就诊的糖尿病患者进行机会性眼病筛查模型的有效性。
BMC Ophthalmol. 2014 Jun 24;14:81. doi: 10.1186/1471-2415-14-81.
引用本文的文献
1
AI-Assisted Screening for Diabetic Retinopathy and Fundus Abnormalities in a Large-Scale Physical Examination Population.大规模体检人群中糖尿病视网膜病变和眼底异常的人工智能辅助筛查
Clin Ophthalmol. 2025 Aug 22;19:2889-2900. doi: 10.2147/OPTH.S538020. eCollection 2025.
2
AI-Enhanced Fluorescein Angiography Detection of Diabetes-Induced Silent Retinal Capillary Dropout and RNA-Seq Identification of Pre-Symptomatic Biomarkers.人工智能增强荧光素血管造影检测糖尿病诱导的隐匿性视网膜毛细血管缺失及症状前生物标志物的RNA测序鉴定
Biomedicines. 2025 Aug 7;13(8):1926. doi: 10.3390/biomedicines13081926.
3
Red blood cell count and its inverse association with diabetic retinopathy: Exploratory development of a risk assessment model in a retrospective cohort.红细胞计数及其与糖尿病视网膜病变的负相关关系：一项回顾性队列研究中风险评估模型的探索性开发
Front Endocrinol (Lausanne). 2025 Aug 8;16:1571192. doi: 10.3389/fendo.2025.1571192. eCollection 2025.
4
Metformin in Diabetic Retinopathy: Mechanisms, Therapeutic Potential, and Barriers.二甲双胍在糖尿病视网膜病变中的作用机制、治疗潜力及障碍
Cureus. 2025 Jul 7;17(7):e87455. doi: 10.7759/cureus.87455. eCollection 2025 Jul.
5
Comparative analysis of bevacizumab and sorafenib on the survival of retinal ganglion cells in the treatment of retinal diseases.贝伐单抗与索拉非尼治疗视网膜疾病对视网膜神经节细胞存活影响的比较分析
Sci Rep. 2025 Aug 5;15(1):28587. doi: 10.1038/s41598-025-12199-w.
6
Nanoenzymatic SERS bifunctional detection platform based on recognition competition strategy for ultrasensitive detection of diabetic retinopathy-related biomarkers.基于识别竞争策略的纳米酶表面增强拉曼散射双功能检测平台用于超灵敏检测糖尿病视网膜病变相关生物标志物
Front Bioeng Biotechnol. 2025 Jul 18;13:1623332. doi: 10.3389/fbioe.2025.1623332. eCollection 2025.
7
Exploration of the potential therapeutic benefits of naringenin against diabetic retinopathy through a National comprehensive cross-sectional study and in vitro experiments.通过一项全国性综合横断面研究和体外实验探索柚皮素对糖尿病性视网膜病变的潜在治疗益处。
Diabetol Metab Syndr. 2025 Aug 1;17(1):304. doi: 10.1186/s13098-025-01879-2.
8
Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography.法西单抗治疗糖尿病性黄斑水肿的疗效以及光学相干断层扫描（OCT）和OCT血管造影中与法西单抗相关的变化
Pharmaceutics. 2025 Jun 30;17(7):858. doi: 10.3390/pharmaceutics17070858.
9
Risk prediction models for diabetic retinopathy: a systematic review.糖尿病视网膜病变的风险预测模型：一项系统综述。
Front Endocrinol (Lausanne). 2025 Jul 11;16:1556049. doi: 10.3389/fendo.2025.1556049. eCollection 2025.
10
Evaluating pentraxin 3 as a diagnostic biomarker for diabetic retinopathy: a systematic review and meta-analysis.评估五聚体3作为糖尿病视网膜病变的诊断生物标志物：一项系统综述和荟萃分析。
Diabetol Metab Syndr. 2025 Jul 16;17(1):273. doi: 10.1186/s13098-025-01849-8.
本文引用的文献
1
Combined effect of diabetic retinopathy and diabetic kidney disease on all-cause, cancer, vascular and non-cancer non-vascular mortality in patients with type 2 diabetes: A real-world longitudinal study.2 型糖尿病患者糖尿病视网膜病变和糖尿病肾病对全因、癌症、血管和非癌症非血管死亡率的综合影响：一项真实世界的纵向研究。
J Diabetes Investig. 2020 Sep;11(5):1170-1180. doi: 10.1111/jdi.13265. Epub 2020 May 17.
2
Screening for diabetic retinopathy: new perspectives and challenges.糖尿病视网膜病变筛查：新视角与新挑战。
Lancet Diabetes Endocrinol. 2020 Apr;8(4):337-347. doi: 10.1016/S2213-8587(19)30411-5. Epub 2020 Feb 27.
3
Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: An analysis using real-world long-term follow-up data.门诊餐后高血糖对2型糖尿病患者视网膜病变发生率的影响：一项使用真实世界长期随访数据的分析
J Diabetes Investig. 2020 Jul;11(4):930-937. doi: 10.1111/jdi.13194. Epub 2020 Jan 2.
4
Diabetes-related kidney, eye, and foot disease in Taiwan: An analysis of nationwide data from 2005 to 2014.台湾地区糖尿病相关的肾脏、眼睛和足部疾病：2005 年至 2014 年全国数据分析。
J Formos Med Assoc. 2019 Nov;118 Suppl 2:S103-S110. doi: 10.1016/j.jfma.2019.07.027. Epub 2019 Aug 30.
5
Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.1 型糖尿病视网膜病变的危险因素：DCCT/EDIC 研究。
Diabetes Care. 2019 May;42(5):875-882. doi: 10.2337/dc18-2308. Epub 2019 Mar 4.
6
Homocysteine: A Potential Biomarker for Diabetic Retinopathy.同型半胱氨酸：糖尿病视网膜病变的一种潜在生物标志物。
J Clin Med. 2019 Jan 19;8(1):121. doi: 10.3390/jcm8010121.
7
Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.连续血糖监测评估的血糖变异性与成人隐匿性自身免疫糖尿病和 2 型糖尿病患者糖尿病视网膜病变的风险。
J Diabetes Investig. 2019 May;10(3):753-759. doi: 10.1111/jdi.12957. Epub 2018 Nov 7.
8
Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus.2 型糖尿病患者糖尿病视网膜病变和糖尿病肾病进展的危险因素之间的不一致性。
J Diabetes Investig. 2019 May;10(3):745-752. doi: 10.1111/jdi.12953. Epub 2018 Nov 7.
9
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.全视网膜光凝与玻璃体内雷珠单抗治疗增生性糖尿病视网膜病变的 5 年疗效比较：一项随机临床试验。
JAMA Ophthalmol. 2018 Oct 1;136(10):1138-1148. doi: 10.1001/jamaophthalmol.2018.3255.
10
Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy.晚期糖基化终末产物在糖尿病视网膜病变发病机制中的作用
Cell Physiol Biochem. 2018;48(2):705-717. doi: 10.1159/000491897. Epub 2018 Jul 19.
Zotero 插件